Shows potential effectiveness of HD-tDCS for symptoms in Parkinson's patients, suggesting new treatment options.
Two-session HD-tDCS at a 30-minute interval targeting the left dorsolateral prefrontal cortex is a safe, well-tolerated, and potentially effective intervention for depressive and cognitive symptoms in patients with mild-to-moderate PD.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: